Introduction {#s1}
============

β~2~AR plays important roles in cardiovascular and pulmonary physiology [@pone.0042658-Pleger1], [@pone.0042658-Insel1]. Upon activation by catecholamines, β~2~AR couples to stimulatory G protein, and activates adenylate cyclase (AC) to produce cAMP. cAMP-dependent PKA phosphorylates various proteins in cardiomyocytes, such as phospholamban, L-type calcium channel, and troponins, resulting in increased heart contraction force and rate [@pone.0042658-Xiang1].

Recently, PDE4D enzymes have been shown to control basal levels of receptor phosphorylation by PKA via binding to β~1~AR and β~2~AR and controlling local cAMP levels [@pone.0042658-Mongillo1], [@pone.0042658-Xiang2]. Specifically, β~1~AR selectively binds to PDE4D8 [@pone.0042658-Richter1] whereas β~2~AR binds broadly to different PDE4D isoforms with strongest binding to PDE4D9 at basal condition [@pone.0042658-DeArcangelis1]. Moreover, agonist stimulation leads to β~2~AR association with PDE4D5 and PDE4D8 specifically. The recruitment of PDE4D isoforms plays a critical role in controlling the spatiotemporal distribution of cAMP signal for selective activation of PKA, and subsequent phosphorylation of substrates for contractile responses [@pone.0042658-DeArcangelis1].

Over the last decade, several types of post-translational modifications on β~2~AR have been characterized. They are implicated in receptor structure and signaling in mammalian cells [@pone.0042658-Vaughan1]--[@pone.0042658-Moffett1]. Among them, the role of β~2~AR phosphorylation by G protein-coupled receptor kinases (GRKs) has been implicated in receptor association with PDE4D enzymes. Upon agonist stimulation, GRK-mediated β~2~AR phosphorylation leads to recruitment of β arrestin 2, which serves as a scaffold protein to recruit PDE4D5 and PDE4D8 [@pone.0042658-DeArcangelis1]. The increased binding of PDE4D isoforms to the activated receptor plays an essential role in confining the cAMP-PKA activities in local environments and dictating the specificity of receptor signaling. In comparison, the role of β~2~AR palmitoylation and its effects on receptor signaling and function in cardiomyocytes remain to be addressed.

Palmitoylation can be enhanced by isoproterenol stimulation [@pone.0042658-ODowd1], [@pone.0042658-Loisel1]. Losing β~2~AR palmitoylation leads to higher basal cAMP-PKA activity. Early studies suggest that the palmitoylation of β~2~AR reduces the receptor coupling to Gs proteins for activation of adenylate cyclase and PKA phosphorylation of receptor in Chinese hamster fibroblasts [@pone.0042658-Moffett2], the functional implication remains unclear. In this context, we hypothesize that palmitoylation of β~2~AR affects the receptor signaling and function in cardiomyocytes.

Thus, we set out to study how β~2~AR palmitoylation influences receptor signaling pathway in cardiomyocytes. Specifically, we like to examine whether palmitoylation of β~2~AR affects agonist-induced receptor trafficking and receptor association with other effectors like PDE4D isoforms in signaling complex. Here, we validate that mutation of β~2~AR at palmitoylation site C341A leads to less cAMP production on the plasma membrane, consistent with the impaired Gs/AC signaling as previously reported. More interestingly, we find that the mutant receptor displays reduced association with PDE4Ds, due to that it has reduced recruitment of β arrestin-2. Surprisingly, the mutant receptor is able to internalize via an arrestin-independent pathway. Therefore, the mutant receptor internalizes alone without recruitment of PDE4Ds, leading to altered spatial distribution of cAMP signal in cardiomyocytes, low cAMP signal at the plasma membrane, and higher cAMP signal in the cytoplasm. Functionally, inhibition of β~2~AR palmitoylation or mutation of cysteine 341 leads to higher PKA activity in the cytoplasm and increase in myocyte contraction rate. In conclusion, our data indicate that palmitoylation of β~2~AR is required for receptor association with arrestin-PDE4Ds to shape subcellular cAMP level in cardiomyocytes for contraction response.

Materials and Methods {#s2}
=====================

Site Mutagenesis, Adenovirus Preparation and Cell Culture {#s2a}
---------------------------------------------------------

Mouse β~2~AR palmitoylation mutant (flag-β~2~AR-C341A) was generated through site directed mutagenesis of cysteine 341 of β~2~AR to alanine using pCDNA3.1-flag-β~2~AR as DNA template. The mutant was sequenced and subcloned into adenovirus vector pAdEasy-1 through recombination in bacteria BJ5831 for adenovirus production in HEK293-QBI cells. Adenoviruses expressing, N terminal PDE4D5-GFP, PDE4D8-GFP, PDE4D9-GFP, and full length PDE4D5-RFP, PDE4D9-HA were created as described previously [@pone.0042658-DeArcangelis1]. Adenoviruses expressing adenylate cyclase isoform VI (AC-VI) had been reported previously [@pone.0042658-DeArcangelis2]. AKAP79-GFP was a gift from Dr. John Scott (University of Washington). Dominant negative β arrestin 2-V54D and dynamin K44E were described elsewhere [@pone.0042658-Wang1]. HEK293 cells and mouse embryonic fibroblasts [@pone.0042658-DeArcangelis1] (MEFs, a gift from Dr. Robert Lefkowitz, Duke University) lacking arrestin genes were cultured in Dulbecco's Modified Eagle's Medium (DMEM) media before transfected with plasmids expressing receptors and other constructs as indicated. Cells were stimulated before being processed for immunofluorescence imaging.

Neonatal Cardiomyocytes Isolation, Total Intracellular cAMP Measurement, and Myocyte Contraction Rate Measurement {#s2b}
-----------------------------------------------------------------------------------------------------------------

β~1~AR and β~2~AR double knockout (β~1~β~2~AR-KO) cardiomyocytes were isolated by digestion of neonatal mouse heart tissue with type II collagenase (Worthington, NJ) and cultured in DMEM supplied with 10% fetal bovine serum. After overnight culture, cells were washed with phosphate buffered saline (PBS) to remove dead cells and then infected with adenoviruses expressing β~2~AR, β~2~AR-C341A for 24 hours. For total intracellular cAMP measurement, cells were treated in the presence or absence of 10 µM isoproterenol for 5 minutes or β~2~AR selective inverse agonist ICI118551 (1 µM, Tocris, MN) for 30 minutes. Cells were treated with 2-bromopalmitic acid (100 µM, Sigma, MO) 15 minutes to inhibit palmitoylation of β~2~AR, which has half-life of 9.8 minutes [@pone.0042658-Loisel1]. Total intracellular cAMP level was measured using cAMP HTS immunoassay kit (Millipore, MA). Detailed procedure for measuring myocyte contraction rate has been described previously [@pone.0042658-Xiang3].

Radioligand Binding Assay {#s2c}
-------------------------

Neonatal cardiomyocytes overexpressing flag-β~2~AR or flag-β~2~AR-C341A were washed once with cold PBS, harvested into hypotonic lysis buffer (20 mM HEPES, pH 7.4, 1 mM EDTA, 1 mM PMSF, and 1 mM benzamidine). Cells were homogenized for 20 strokes in a tight homogenizer followed by centrifugation for 10 minutes at 800 g to remove nuclei and unbroken cells. The supernatant was further spun down for 20 minutes at 18,000 rpm using a Beckman JC-M2 rotor to pellet the membrane, which was resuspended by passage through 25-gauge needle in 1× binding buffer (75 mM Tris-HCl, pH 7.4, 12.5 mM MgCl~2~, 1 mM EDTA). After measuring protein concentration by BCA assay (Pierce, IL), 20 µg of membrane protein containing β~2~AR was incubated with 10 nM \[^3^H\] dihydroalprenolol (GE Healthcare, Piscataway, NJ) for 1 hour at shaken speed of 230 rpm under room temperature. 20 µg of membrane proteins from cardiac cells without overexpression of β~2~AR were used as control. Membranes were harvested and rinsed with 1× binding buffer. The membrane-bound \[^3^H\] dihydroalprenolol was detected using a Beckman LS 6500 liquid scintillation counter (Beckman Coulter, Fullerton, CA).

Receptor Internalization and Recycling {#s2d}
--------------------------------------

β~1~β~2~AR-KO cardiomyocytes were infected with adenoviruses expressing flag-β~2~AR, flag-β~2~AR-C341A for 24 hours. Cells were serum starved for 30 minutes, and in some cells, treated with 2 µg/ml filipin for 30 minutes, and then stimulated with 10 µM isoproterenol for different time as indicated to examine receptor internalization. For determination of receptor recycling, cells were stimulated with 10 µM isoproterenol for 10 minutes followed by drug removal to allow receptor recycling for 30 minutes and 60 minutes. Cells were fixed with 4% paraformaldehyde and permeabilized with 0.2% Nonidet P-40 and stained with anti-flag antibody (mouse IgG~2b~, Sigma, MO), followed by Alex-594 conjugated secondary antibody against mouse IgG~2b~ (Invitrogen, CA). Images were captured with a CCD camera on a Zeiss microscope with MetaMorph software. Quantification of receptor internalization and recycling using FLISA method had been described in previous studies [@pone.0042658-Swaminath1].

Purification of Caveolin-rich Membrane Fractions {#s2e}
------------------------------------------------

Neonatal cardiomyocytes expressing flag-β~2~AR or flag-β~2~AR-C341A were collected into cold PBS and harvested by centrifugation. Cells were resuspended in 2 ml 0.5 M Na~2~CO~3~ (pH∼11). After gentle vortexing, 1.75 ml sample was mixed with 1.75 ml 80% sucrose buffer (25 mM MES, pH 6.5, 0.15 M NaCl, 80% sucrose) and loaded onto the bottom of ultracentrifuge tube. A two-step gradient was loaded onto the top of the sample with 3.5 ml 35% sucrose buffer (25 mM MES, 0.15 M NaCl, 250 mM Na~2~CO~3~, 35% sucrose) and 4 ml 5% sucrose buffer (25 mM MES, 0.15 M NaCl, 250 mM Na~2~CO~3~, 5% sucrose). Sample was spun down in a Beckman SW41 rotor for 18 hours at 38,000 rpm. 1 ml fraction was collected from top to bottom and mixed with 10% trichloroacetic acid for protein precipitation for 4 hours on ice. The protein pellet was dissolved in 1× SDS-sample buffer. Proteins after precipitation was collected by centrifugation for 30 minutes at 13,200 rpm, washed twice with 100% cold acetone and dissolved in 1× SDS-sample buffer. Proteins were separated by 12% SDS-PAGE for detection of caveolin-3 (BD, NJ), flag-β~2~AR or flag-β~2~AR-C341A by anti-flag antibody (Sigma, MO), and Src (Cell Signaling, MA).

Co-immunoprecipitation and Western Blot {#s2f}
---------------------------------------

Cells overexpressing flag-β~2~AR, flag-β~2~AR-C341A, or together with individual PDE4D isoforms or GFP-β arrestin 2 were stimulated with 10 µM isoproterenol and harvested into lysis buffer (20 mM HEPES, pH 7.4, 0.6% Nonidet P-40, 150 mM NaCl, 2 mM EDTA, 10% glycerol, 0.03% n-Dodecyl-β-D-maltoside (Enzo Life Sciences, PA), 1 mM PMSF, 1 mM benzamidine, 1 mM NaF, 1 mM Na~3~VO~4~). Protein samples were lysed for 40 minutes at 4°C before centrifugation for 10 minutes at 16,000 g to collect supernatant. Receptors were immunoprecipitated by anti-flag M2 affinity resin (Sigma, MO) for 2 hours at 4°C and eluted into 2x SDS-sample buffer for SDS-PAGE. After transfer onto nitrocellulose membrane, proteins were blotted with 5% non-fat milk in 1x TBST and subsequently blotted with the following antibodies: endogenous PDE4 (Abcam, CA), GFP (Clontech, CA), anti-flag (Sigma, MO), caveolin-3 (BD, NJ), RFP (Thermofisher, IL), HA (Covance, CA). The optical density of the bands was analyzed with ImageJ (National Institute of Health, MD, USA).

Receptor Phosphorylation {#s2g}
------------------------

Cardiomyocytes expressing flag-β~2~AR or flag-β~2~AR-C341A were serum starved for 30 minutes before stimulation with 10 µM isoproterenol for different time as indicated. Proteins were harvested and subjected to SDS-PAGE for Western blot with antibodies against total β~2~AR, phospho-β~2~AR by PKA on serines 261/262 [@pone.0042658-Liu1], and phospho-β~2~AR by GRK on serines 355/356 (SCBT, CA).

Fluorescence Resonance Energy Transfer (FRET) {#s2h}
---------------------------------------------

The detailed procedures to measure real time cAMP/PKA activity in living cardiomyocytes using the FRET technique described in previous study [@pone.0042658-Liu1]. In brief, β~1~β~2~AR-KO neonatal cardiomyocytes were infected with adenoviruses expressing β~2~AR or β~2~AR-C341A, along with cytoplasmic cAMP FRET biosensor ICUE3, plasma membrane targeted cAMP FRET biosensor PM-ICUE3, or PKA FRET biosensor AKAR2.2 [@pone.0042658-Dipilato1], [@pone.0042658-Soto1]. After overnight expression, cells were washed twice with PBS and challenged by 10 nM or 10 µM isoproterenol as indicated. Cells were treated with 2-bromopalmitic acid (100 µM, Sigma, MO) 15 minutes to inhibit palmitoylation of β~2~AR. Rolipram was added at final concentration of 10 µM to inhibit all PDE4 activities in the cells. Images were captured every 20 seconds and the ratio between emission of YFP and that of CFP was plotted as an indicator of dynamic activity change that was automatically analyzed by Metafluor software. Basal line substraction was performed using Origin software. Data analysis was performed by GraphPad Prism software.

Statistical Analysis {#s2i}
--------------------

All statistical analyses were performed using GraphPad Prism software. p\<0.05 was considered statistically significant.

Results {#s3}
=======

Disruption of Palmitoylation of β~2~AR Enhances Agonist-induced cAMP-PKA Activation in the Cytoplasm and Myocyte Contraction Response {#s3a}
-------------------------------------------------------------------------------------------------------------------------------------

We used two complimentary strategies to examine the functional implication of palmitoylation of β~2~AR in cardiomyocytes. First, a point mutation was introduced on human β~2~AR to generate β~2~AR-C341A, in which the cysteine residue was replaced by alanine. Both mutant and wild type β~2~AR were expressed in cardiomyocytes lacking endogenous β~1~ and β~2~ARs (DKO). Activation of the mutant β~2~AR-C341A by 10 µM of isoproterenol induced a higher increase in myocyte contraction rate than wild type receptor ([Figure 1A](#pone-0042658-g001){ref-type="fig"}) even though both receptors displayed equivalent expression measured by \[^3^H\] dihydroalprenolol ligand binding and by Western blot ([Figure 1B](#pone-0042658-g001){ref-type="fig"}). Second, we applied 2-bromopalmitic acid to inhibit receptor palmitoylation [@pone.0042658-Kwiatkowska1], which selectively enhanced the contraction rate increase induced by wild type receptor, but not those by C341A mutant ([Figure 1A](#pone-0042658-g001){ref-type="fig"}). To validate the observation of functional contraction response, we examined the cAMP activities in the cytoplasm, which is relevant to PKA activation at the intracellular compartments such as sarcoplasmic reticulum, calcium storage for cellular calcium signaling and contractile response. We applied the cytoplasmic cAMP FRET sensor ICUE3 to measure the cAMP dynamics. Activation of β~2~AR-C341A induced higher cAMP FRET responses than WT receptor in the cytoplasm ([Figure 1C and 1E](#pone-0042658-g001){ref-type="fig"}). Inhibition of receptor palmitoylation with 2-bromopalmitic acid selectively enhanced the cAMP FRET signals in the cytoplasm induced by WT β~2~AR but not by β~2~AR-C341A, and abolished the difference between the two receptors ([Figure 1D and 1E](#pone-0042658-g001){ref-type="fig"}). These data are consistent with the cAMP accumulation measured by cAMP immunoassay in cell lysates ([Figure S1](#pone.0042658.s001){ref-type="supplementary-material"}). In agreement with cAMP data, activation of β~2~AR-C341A by isoproterenol induced higher increases in PKA activities measured by FRET biosensor AKAR2.2 in the cytoplasm than WT β~2~AR ([Figure 1F](#pone-0042658-g001){ref-type="fig"}). 2-bromopalmitic acid treatment selectively enhanced increases in PKA activities induced by stimulation of WT β~2~AR ([Figure 1E](#pone-0042658-g001){ref-type="fig"}).

![Stimulation of palmitoylation mutant β~2~AR leads to higher and sustained intracellular cAMP-PKA activities and higher increases in cardiomyocyte contraction rate.\
β~1~β~2~AR-KO cardiomyocytes expressing β~2~ARs via adenovirus infection were stimulated with isoproterenol (10 µM). The spontaneous contraction rate was recorded before and after isoproterenol stimulation. A) Quantification of isoproterenol-induced cardiomyocyte contraction rate increases over the baseline levels was plotted in the absence or presence of treatment with 2-bromopalmitic acid. B) 20 µg membrane protein containing β~2~ARs was determined by radioligand \[^3^H\] DHA binding to measure expression levels of β~2~AR and β~2~AR-C341A. The expressed receptors were also detected by Western blot using anti-flag antibody. β~1~β~2~AR-KO cardiomyocytes expressing β~2~ARs together with cytoplasmic cAMP FRET biosensor ICUE3 (C-E) or PKA activity biosensor AKAR 2.2 (F). (C) and (D) Cells were stimulated with isoproterenol (10 µM) to record the changes of FRET ratio. 2-Bro, 2-bromopalmitic acid (100 µM) was added 15 minutes before Iso stimulation; Quantification of isoproterenol-induced maximal increases in cAMP FRET ratio (E) and PKA FRET ratio (F) was plotted. In each panel, bar graphs were average from the maximal increases in the indicated number of cells (FRET assay) or dishes (beating assay) from at least three independent experiments. \*, p\<0.05 in comparison to WT control stimulated with Iso alone by one-way ANOVA; \#, p\<0.05 between WT and C341A stimulated with Iso by two-way ANOVA.](pone.0042658.g001){#pone-0042658-g001}

Disruption of Palmitoylation of β~2~AR Alters Spatio-temporal Distribution of Agonist-induced cAMP in Cardiomyocytes {#s3b}
--------------------------------------------------------------------------------------------------------------------

Previous study on β~2~AR palmitoylation in Chinese hamster fibroblasts suggests that mutation of the palmitoylation residue reduces β~2~AR/Gs coupling to activate adenylate cyclases for cAMP production on the isolated plasma membrane [@pone.0042658-ODowd1]. Here, we observed that intracellular cAMP and PKA levels in myocytes expressing β~2~AR-C341A were higher than those with WT receptor, leading higher contraction rate response under agonist stimulation ([Figure 1](#pone-0042658-g001){ref-type="fig"}). This observed difference suggests a potential alteration of subcellular distribution of cAMP signal between the plasma membrane and the cytoplasm under stimulation of the mutant β~2~AR-C341A. Besides Gs/AC-dependent cAMP production, the cAMP dynamics can also be modulated by β~2~AR-associated PDE4D for cAMP degradation [@pone.0042658-DeArcangelis1], [@pone.0042658-DeArcangelis2]. We envisioned that the mutant receptor also caused alteration in the membrane trafficking of β~2~AR and its associated PDE4D. To test this hypothesis, we first tried to validate the coupling efficiency between the mutant receptor and Gs/AC axis. We applied the plasma membrane-localized FRET biosensor to directly measure cAMP in the local domain produced by receptor activation in living myocytes. By using a low concentration of 10 nM isoproterenol, at which the ligand-bound receptor only activates Gs protein without undergoing internalization and Gi coupling [@pone.0042658-Liu1], we selectively analyzed receptor/Gs coupling of the mutant β~2~AR-C341A. At minimal 10 nM isoproterenol, β~2~AR-C341A induced a lower cAMP FRET response at the plasma membrane than WT receptor ([Figure 2A](#pone-0042658-g002){ref-type="fig"}). Inhibition of PDE4 with rolipram enhanced the FRET responses induced by both receptors, but the difference between increases induced by two receptors still remained ([Figure 2A](#pone-0042658-g002){ref-type="fig"}). These data are consistent with previous publications showing that the mutant β~2~AR-C341A has impaired coupling to Gs protein for cAMP production [@pone.0042658-ODowd1]. At the same concentration of isoproterenol stimulation, β~2~AR-C341A induced a lower cAMP FRET response in the cytoplasm than WT receptor ([Fig. 2C](#pone-0042658-g002){ref-type="fig"}). However, at 10 µM isoproterenol stimulation, while the cAMP signals at the plasma membrane induced by C341A was lower than wild type receptor ([Figure 2B](#pone-0042658-g002){ref-type="fig"}), the cAMP signal in the cytoplasm induced by C341A was higher than wild type receptor ([Figure 2D](#pone-0042658-g002){ref-type="fig"}). We hypothesize that the trafficking of activated receptor and its associated PDE4D shape the subcellular cAMP signals at high concentration of isoproterenol stimulation. In supporting this notion, inhibition of PDE4 enhanced cAMP signals and normalized the difference between the two receptors in both measurements of cAMP in the cytoplasm by FRET assay and cAMP accumulation by immunoassay ([Figure S2](#pone.0042658.s002){ref-type="supplementary-material"}).

![Mutation of palmitoylation reduces β~2~AR/G protein-dependent cAMP production in cardiomyocytes.\
β~1~β~2~AR-KO cardiomyocytes were infected with adenoviruses expressing β~2~ARs together with the plasma membrane-targeted cAMP FRET biosensor PM-ICUE3 (A and B) or cytoplasmic cAMP FRET biosensor ICUE3 (C and D). Cells were stimulated with 10 nM of isoproterenol (A and C) or 10 µM of isoproterenol (B and D). The maximal increases in FRET ratio were plotted. Rol, rolipram, was added together with Iso at 10 µM. Bar graphs were average from the maximal increases in time courses. \*, p\<0.05 by *t*-test in comparison to WT β~2~AR.](pone.0042658.g002){#pone-0042658-g002}

Disruption of Palmitoylation of β~2~AR Reduces Receptor Association with PDE4D Isoforms at Both Resting and Stimulating Conditions {#s3c}
----------------------------------------------------------------------------------------------------------------------------------

We then examined the association of PDE4D with mutant β~2~AR-C341A. β~2~AR-C341A displayed a reduced association with PDE4 in both HEK293 cells and neonatal cardiomyocytes ([Figure 3A and 3C](#pone-0042658-g003){ref-type="fig"}). In contrast, mutant β~2~AR-C341A did not change the receptor association with adenylate cyclase VI, one of the major adenylate cyclase isoforms expressed in cardiomyocytes as well as the receptor complex scaffold protein AKAP79 ([Figure 3B and 3D](#pone-0042658-g003){ref-type="fig"}). These data indicate that the mutation on β~2~AR palmitoylation site at C341 selectively reduces receptor association with PDE4 without globally disrupting association with AKAP and adenylate cyclase.

![Palmitoylation is required for β~2~AR association with phosphodiesterase 4.\
Cells expressing flag-β~2~ARs alone (A and C) or together with adenylate cyclase VI (B), AKAP-GFP (D), GFP-PDE4D (E), or PDE4D9-HA (F) were lysed for immunoprecipitation with anti-flag M2 beads. The bound proteins were detected in Western blot by anti-flag, anti-GFP, anti-PDE4, anti-adenylate cyclase VI, anti-GFP, and anti-HA antibodies. Western blot was quantified and normalized against the IP protein. Bar graphs were average from 3--5 different experiments. \*, p\<0.05 by *t*-test between WT and C341A.](pone.0042658.g003){#pone-0042658-g003}

Among four PDE4 subfamilies, PDE4D subfamily contribute to 60% of total PDE4 enzymatic activities and regulate βAR signaling in cardiomyocytes [@pone.0042658-Mongillo1]. Nine PDE4D isoforms have been identified which share identical catalytic domains and unique N terminal for distinct subcellular localization [@pone.0042658-Richter2]. We have previously reported differential association of PDE4D enzymes with β~2~AR in cardiomyocytes at resting and stimulating conditions to modulate receptor-induced cAMP signal [@pone.0042658-DeArcangelis1]. Only PDE4D9 displayed less association with β~2~AR-C341A at basal condition, consistent with the prominent role of this enzyme in controlling local cAMP and basal PKA phosphorylation of protein in receptor complex at resting state ([Figure 3E](#pone-0042658-g003){ref-type="fig"} and [@pone.0042658-DeArcangelis1]). Consistently, overexpression dominant negative PDE4D9 or inhibition of PDE4 selectively enhanced cAMP levels in cells expressing wild type receptor, but not in those expressing β~2~AR-C341A at resting state ([Figure S3](#pone.0042658.s003){ref-type="supplementary-material"}).

Arrestin plays a role in PDE4D association with β~2~AR in resting state [@pone.0042658-DeArcangelis1]. We then investigated whether palmitoylation regulates the association among PDE4D isoforms, arrestins, and β~2~AR. Consistent with the data in cardiomyocytes, β~2~AR-C341A displayed less association with PDE4D9 than WT receptor at resting state in WT MEFs, but not in MEFs lacking arrestin proteins ([Figure 3F](#pone-0042658-g003){ref-type="fig"}), indicating a necessary role of arrestin in mediating palmitoylation-dependent binding of β~2~AR to PDE4D9. Upon agonist stimulation, PDE4D5 and PDE4D8, but not PDE4D9 are recruited to the activated receptor via scaffold protein β arrestin 2 ([Figure 4A--4C](#pone-0042658-g004){ref-type="fig"} and [@pone.0042658-DeArcangelis1]). However, the recruitment of both PDE4D5 and 4D8 to β~2~AR-C341A was significantly reduced compared with that to WT β~2~AR ([Figure 4A--4B](#pone-0042658-g004){ref-type="fig"}), indicating the necessary role of palmitoylation for the β arrestin 2-dependent association of PDE4D with activated β~2~AR. Moreover, loss of β arrestin 2 abolished the agonist-induced recruitment of PDE4D5 to WT β~2~AR in MEFs ([Figure 4D](#pone-0042658-g004){ref-type="fig"}), further validating the critical role of β arrestin 2 in scaffolding PDE4Ds for regulating β~2~AR signaling.

![Palmitoylation of β~2~AR is required for agonist-dependent recruitment of arrestin-PDE4D complexes to the receptor.\
β~1~β~2~AR-KO cardiomyocytes expressing flag-β~2~ARs together with GFP-PDE4D5 (A), GFP-PDE4D8 (B), or GFP-PDE4D9 (C) were serum-starved for 30 minutes before stimulation with 10 µM of isoproterenol as indicated. Cell lysates were incubated with anti-flag M2 beads for co-immunoprecipitation of β~2~ARs and PDE4D proteins. The bound proteins were detected in Western blot by anti-flag and anti-GFP antibodies as indicated. D) Flag-β~2~ARs and PDE4D5-RFP were expressed in wild type and arrestins double knockout (KO) MEF cells. Co-IP was done like those in panel (A--C). The bound proteins were detected in Western blot by anti-flag and anti-RFP antibodies as indicated. Western blot was quantified and normalized against the IP protein. Bar graphs were average from 3--5 different experiments. \*, p\<0.05 by one-way ANOVA in comparison to WT β~2~AR without stimulation. ^\#^, p\<0.05 by *t*-test to WT control.](pone.0042658.g004){#pone-0042658-g004}

![Palmitoylation of cysteine 341 of β~2~AR is required for agonist-induced recruitment of β arrestin 2, but not receptor phosphorylation by PKA and GRK.\
β~1~β~2~AR-KO cardiomyocytes expressing flag-β~2~ARs and β arrestin 2-GFP were serum-starved for 30 minutes before stimulation with 10 µM of isoproterenol as indicated. (A) Cell lysates were incubated with anti-flag M2 beads to immunoprecipitate flag-β~2~ARs. The bound proteins were detected in Western blot by anti-flag and anti-GFP antibodies. \*, p\<0.05 by *t*-test in comparison to the control without stimulation. (B) Cell lysates were used to detect receptor phosphorylation by PKA on serine 261/262 or GRKs on serine 355/356 by anti-phospho-serine 261/262 and anti-phospho-serine 355/356 specific antibodies as indicated. Western blots were quantified and normalized against the total β~2~AR expression. Bar graphs were average from 3--5 different experiments. ^\#^, p\<0.05 by two-way ANOVA in comparison to WT control.](pone.0042658.g005){#pone-0042658-g005}

Disruption of Palmitoylation of β~2~AR Reduces Recruitment of Arrestin to the Phosphorylated Receptor Under Agonist Stimulation {#s3d}
-------------------------------------------------------------------------------------------------------------------------------

The agonist-induced binding of PDE4D to activated β~2~AR is dependent on the recruitment of arrestin. We suspected that the agonist-induced recruitment of β arrestin 2 to βAR is reduced by mutation of the palmitoylation site. In cardiomyocytes, β arrestin 2 had abundant expression whereas β arrestin 1 expression was low ([Figure S4](#pone.0042658.s004){ref-type="supplementary-material"}). β~2~AR-C341A displayed a reduced recruitment of β arrestin 2 upon agonist stimulation when compared to wild type receptor ([Figure 5A](#pone-0042658-g005){ref-type="fig"}). The recruitment of arrestin is dependent on receptor phosphorylation by GRK. Surprisingly, β~2~AR-C341A displayed normal phosphorylation by GRKs in comparison to the wild type β~2~AR upon isoproterenol stimulation. PKA phosphorylation of β~2~AR-C341A was higher at resting condition than wild type receptor; and the agonist-induced PKA phosphorylation was more sustained compared to that of WT β~2~AR ([Figure 5B](#pone-0042658-g005){ref-type="fig"} and [Figure S5](#pone.0042658.s005){ref-type="supplementary-material"}). This is consistent with previous report on higher PKA phosphorylation of mutant C341G receptor expressed in fibroblasts [@pone.0042658-Moffett2], [@pone.0042658-Moffett3]. Phosphorylation of β~2~AR plays a significant role in receptor desensitization through β arrestin-dependent pathway [@pone.0042658-Vaughan1]. The observation of normal GRK phosphorylation but reduced recruitment of β arrestin 2 to β~2~AR-C341A ([Figure 5A and 5B](#pone-0042658-g005){ref-type="fig"}) prompted us to examine arrestin-dependent receptor internalization after agonist stimulation. To our surprise, β~2~AR-C341A displayed normal time-dependent internalization similar to that of WT receptor ([Figure 6A and 6B](#pone-0042658-g006){ref-type="fig"}). Moreover, both WT and C341A mutant displayed sufficient recycling upon isoproterenol removal ([Figure 6A and 6C](#pone-0042658-g006){ref-type="fig"}). Consequently, the cAMP signal induced by either wild type or mutant β~2~AR-C341A were sensitive to inhibition of Gi ([Figure S6](#pone.0042658.s006){ref-type="supplementary-material"}), indicating that both receptors are capable to couple to Gi after agonist-induced receptor translocation [@pone.0042658-Wang2], [@pone.0042658-Xiang4]. As a control, a β~2~AR lacking critical GRK sites for arrestin binding and internalization showed impaired internalization ([Figure 6A and 6D](#pone-0042658-g006){ref-type="fig"}), consistent with early studies showing that β~2~AR internalization is dictated by GRK phosphorylation in cardiomyocytes [@pone.0042658-Liu1].

![Mutation of palmitoylation site does not inhibit agonist-induced β~2~AR trafficking.\
A) β~1~β~2~AR-KO cardiomyocytes expressing wild type or mutant flag-β~2~ARs were stimulated with 10 µM isoproterenol to examine receptor internalization or followed by agonist removal to examine receptor recycling. Receptors were stained by anti-flag antibody M1 and Alex 488-conjugated goat-anti-mouse secondary antibody. Maximal internalization of different flag-β~2~ARs in β~1~β~2~AR-KO cardiomyocytes at 30 minute of stimulation was plotted in bar graph. Receptors remaining on the cell surface after internalization (B and D) or recycling (C) were quantified using Alex 488-conjugated flag antibody labeling. Quantitative measurements of cell surface receptor were average from at least three different experiments. \*, p\<0.05 by *t*-test in comparison to WT β~2~AR.](pone.0042658.g006){#pone-0042658-g006}

Disruption of Palmitoylation of β~2~AR Alters Agonist-induced Receptor Internalization Pathway {#s3e}
----------------------------------------------------------------------------------------------

We then further explored the mechanism underlying the agonist-induced internalization of β~2~AR-C341A with MEF cells lacking individual arrestin genes. Deletion of β arrestin 2, but not β arrestin 1 gene selectively blocked isoproterenol-induced internalization of WT receptor, but did not affect the internalization of β~2~AR-C341A ([Figure 7](#pone-0042658-g007){ref-type="fig"}). These data indicate that β~2~AR-C341A undergoes internalization via an arrestin-independent pathway. GPCR can undergo internalization via both arrestin- and caveolae-dependent pathways although both pathways are dependent on the dynamin GTPase [@pone.0042658-Zhang1], [@pone.0042658-Plested1]. β~2~AR has been shown to be localized in caveolae/lipid rafts for proper signaling and function [@pone.0042658-Xiang5], we examined whether palmitoylation plays a role in β~2~AR localization in caveolae, thus modulating the receptor trafficking properties upon agonist stimulation. Both β~2~AR and β~2~AR-C341A were enriched in caveolae-rich membrane fraction, which was further supported by co-immunoprecipitation between receptor and caveolin-3 ([Figure 8A and 8B](#pone-0042658-g008){ref-type="fig"}). While β~2~AR and β~2~AR-C341A displayed normal internalization upon isoproterenol stimulation ([Figure 8C](#pone-0042658-g008){ref-type="fig"}), the receptor internalization was completely blocked by overexpression of dominant negative dynamin K44E in HEK293 cells ([Figure 8D](#pone-0042658-g008){ref-type="fig"}). Meanwhile, pretreatment with filipin, a drug that disrupts lipid rafts/caveolae [@pone.0042658-Xiang6], inhibited isoproterenol-induced internalization of β~2~AR-C341A ([Figure 8F](#pone-0042658-g008){ref-type="fig"}). In comparison, overexpression of dominant negative β arrestin 2 V54D only partially inhibited isoproterenol-induced internalization of β~2~AR-C341A ([Figure 8E](#pone-0042658-g008){ref-type="fig"}). Together, these data suggest that β~2~AR-C341A utilizes additional caveolin-dependent pathway for internalization that is dependent on dynamin GTPase.

![Mutation of palmitoylation site allows agonist-induced β~2~AR internalization via an arrestin-independent pathway.\
MEFs (WT, β arrestin 1-KO or β arrestin 2-KO) expressing flag-β~2~ARs or flag-β~2~AR-C341A were serum starved for 30 minutes before stimulation with isoproterenol 10 µM for 30 minutes to examine receptor internalization. A-C), cells were fixed, and receptors were stained by anti-flag antibody M1 and Alex 488-conjugated goat-anti-mouse secondary antibody. D), Cells surface receptor level after agonist stimulation was measured by FLISA method.](pone.0042658.g007){#pone-0042658-g007}

![Mutation of palmitoylation site promotes caveolin-dependent β~2~AR internalization upon agonist stimulation.\
A) Membrane fractionations of β~1~β~2~AR-KO cardiomyocytes expressing β~2~AR or β~2~AR-C341A were blotted with caveolin-3, Src, and flag antibodies. P is the pellet fraction after centrifugation. B) Cell lysates were incubated with M2 beads for immunoprecipitation of flag-β~2~ARs to detect endogenous caveolin-3 association. (C--F) HEK293 cells expressing β~2~AR or together with other proteins were stimulated with 10 µM isoproterenol for 30 minutes to examine receptor internalization. C) Cells expressing flag-β~2~AR alone, D) cells expressing flag-β~2~ARs together dominant negative dynamin K44E, F) cell expressing flag-β~2~ARs were treated with 2 µg/ml filipin for 30 minutes, and E) cells expressing flag-β~2~AR-C341A together with β arrestin 2 (β arr2) or dominant negative β arrestin 2-V54D (β arr2-V54D), before stimulation with isoproterenol 10 µM for 30 minutes to examine receptor internalization. Cells were fixed, and receptors were stained by anti-flag antibody M1 and Alex 594-conjugated goat-anti-mouse secondary antibody.](pone.0042658.g008){#pone-0042658-g008}

Discussion {#s4}
==========

Palmitoylation is a common feature shared by many G-protein coupled receptors. In the present study, we reveal a couple of new functional properties of palmitoylation of β~2~AR in function and signaling. First, palmitoylation of β~2~AR is required for receptor signaling complex formation. Disruption of palmitoylation of β~2~AR selectively abolishes the receptor interaction with β arrestin 2 and PDE4D enzymes for cAMP degradation without affecting the receptor association with AKAP and adenylate cyclase. Second, palmitoylation of β~2~AR modulate the receptor endocytic pathways under agonist stimulation. Mutation on palmitoylation site of β~2~AR shifts the receptor internalization from an arrestin-dependent pathway to a caveolae-dependent pathway. Thus, the mutant β~2~AR is able to undergo internalization without recruiting arrestin and PDE4 enzymes. This leads to altered redistribution of PDE4 enzymes from the plasma membrane to intracellular endosomal compartments, which changes the cAMP dynamics in these subcellular compartments under agonist stimulation of β~2~AR. As a result, activation of the mutant β~2~AR leads to higher intracellular cAMP level in cardiomyocytes to promote stronger PKA activity and myocyte contraction response.

Recent studies provide accumulating evidence on elaborated complex formation of GPCRs with their signaling partners. These data demonstrate a tightly regulated and dynamic equilibrium between the receptor complex with stimulatory adenylate cyclases for second messenger cAMP production and the receptor complex with inhibitory phosphodiesterases for cAMP hydrolysis. β~2~AR is known to bind to AKAP79 and AKAP250 [@pone.0042658-Malbon1], and both AKAP79 and mAKAP is shown to scaffold adenylate cyclases to facilitate signaling transduction efficiency and specificity [@pone.0042658-Dessauer1]. On the contrary, β~2~AR binds to PDE4 enzymes in an arrestin-dependent manner [@pone.0042658-DeArcangelis1], which shapes the spatiotemporal distribution of intracellular cAMP. In one recent example, relaxin receptor is able to form a stable complex with both AKAP79-anchored AC and arrestin-associated PDE4. This complex allows maintaining a tonic cAMP signal induced by the receptor [@pone.0042658-Halls1]. We find that mutation of palmitoylation site on β~2~AR displays a reduced binding to PDE4D without affecting the binding to AKAP79 and AC. This reduced binding of PDE4D9 is due to that the mutant β~2~AR displays a reduced association of β arrestin 2 ([Figure 3](#pone-0042658-g003){ref-type="fig"}), similar to the effect of palmitoylation on the recruitment of arrestin to activated vasopressin receptor [@pone.0042658-Hawtin1]. Under agonist stimulation, the mutant β~2~AR-C341A also displays reduced association with PDE4D5 and PDE4D8 ([Figure 4](#pone-0042658-g004){ref-type="fig"}), which is again due to a reduced recruitment of β arrestin 2 to activated receptor ([Figure 5](#pone-0042658-g005){ref-type="fig"}). Therefore, palmitoylation is required for β~2~AR binding to β arrestin 2, which is necessary to connect PDE4D enzymes to the receptor.

Despite the inability of the mutant β~2~AR-C341A to recruit β arrestin 2, the receptor is able to undergo agonist-induced internalization via a caveolae-dependent pathway. This is consistent with report that β~1~AR is able to internalize via both clathrin and caveolae-dependent pathways in HEK293 cells, which is dependent on receptor phosphorylation by GRK2 and PKA respectively [@pone.0042658-Rapacciuolo1]. Accordingly, the mutant β~2~AR-C341A displays normal GRK phosphorylation but an increased and prolonged PKA phosphorylation under agonist stimulation. The increased PKA phosphorylation may promote PKA-dependent internalization of the mutant receptor via the caveolae-dependent pathway. Meanwhile, mutation of GRK phosphorylation sites reduces agonist-induced internalization, in agreement with the critical role of GRK phosphorylation for arrestin-mediated β~2~AR internalization and desensitization [@pone.0042658-Vaughan1]. Together, both GRK phosphorylation and palmitoylation are necessary for recruitment of arrestin for internalization of the activated β~2~AR; mutation of palmitoylation promotes PKA phosphorylation, and PKA-dependent internalization via caveolae-mediated pathway.

The structural properties involved in palmitoylation for selective binding of receptor to arrestin, but not to AKAPs remains to be determined. The mutant β~2~AR-C341 also displays normal association with caveolin, indicating that the modification is not required for caveolae-targeting. This observation is similar to those palmitoylation sites reported on caveolin-1, but different from palmitoylation-dependent targeting to lipid rafts by other proteins including G protein signaling proteins (RGS) [@pone.0042658-Hiol1], G proteins [@pone.0042658-Resh1], SNAP proteins [@pone.0042658-Gonzalo1], and Ras proteins [@pone.0042658-Dong1]. While the mutant β~2~AR-C341 undergoes internalization via the caveolae-dependent pathway, dominant negative dynamin K44E completely blocks the internalization ([Figure 8F and 8D](#pone-0042658-g008){ref-type="fig"}). The observations are consistent with other studies showing that GPCRs can undergo different internalization pathways including both arrestin-dependent and caveolin-dependent endocytosis [@pone.0042658-Zhang1], [@pone.0042658-Plested1], and both internalization pathways require the activity of dynamin GTPase.

The β~2~AR-induced intracellular cAMP/PKA signaling is shaped by dynamic equilibrium between Gs/AC-mediated cAMP production and PDE-mediated cAMP hydrolysis. The mutant β~2~AR-C341A displays an impaired coupling to Gs protein for cAMP production. Here, the reduced association of PDE4D with mutant β~2~AR-C341A has profound effects on subcellular dynamics of cAMP in cardiac myocytes. The mutant β~2~AR-C341A undergoes internalization without recruiting the PDE4D, which alters the subcellular distribution of PDE4D and contributes to a higher and more sustained intracellular cAMP accumulation under agonist stimulation. Consequently, the mutant β~2~AR-C341A induces higher PKA activity and contraction response in cardiomyocytes. Together, we have shown that palmitoylation of β~2~AR modulates receptor signaling in cardiomyocytes via regulating the receptor-associated complexes. These complexes potentially limit the cAMP signaling in local environments, which not only contributes to receptor signaling specificity but also protects cells from overstimulation.

Supporting Information {#s5}
======================

###### 

**β~1~β~2~AR-KO cardiomyocytes were infected with adenoviruses expressing flag-β~2~AR or flag-β~2~AR-C341A for 24 hours.** A) Total cAMP levels after 5 minutes Iso(10 µM) stimulation were measured using cAMP HTS immunoassay kit. 2-bromopalmitic acid (100 µM) was added 15 minutes before cells were lysed for cAMP assay. Bar graphs represent average from at least three experiments. \*, p\<0.05 in comparison to WT control stimulated with Iso alone by one-way ANOVA.
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###### 

Click here for additional data file.

###### 

\(A\) β~1~β~2~AR-KO cardiomyocytes expressing β~2~ARs along with cAMP FRET biosensor ICUE3 were stimulated with 10 µM isoproterenol. Rolipram (Rol, 10 µM isoproterenol as indicated. The changes in ICUE3 FRET ratio were recorded, and the maximal changes in FRET ratio were plotted. (B) β~1~β~2~AR-KO cardiomyocytes expressing β~2~ARs were stimulated with 10 µM isoproterenol for 5 minutes. Rolipram was added together with isoproterenol as indicated. Cells were lysed and the cAMP accumulations were determined with using cAMP HTS immunoassay kit. Bar graphs represent average from at least three experiments. \*, p\<0.05 in comparison to WT control stimulated with Iso alone by one-way ANOVA.
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Click here for additional data file.

###### 

**β~1~β~2~AR-KO cardiomyocytes expressing β~2~ARs along with dominant negative PDE4D9 as indicated were stimulated with 10 µM isoproterenol for 5 minutes.** Cells were lysed and the cAMP accumulations were determined with using cAMP HTS immunoassay kit. Bar graphs represent average from at least three experiments. \*, p\<0.05 in comparison to WT control stimulated with Iso alone by one-way ANOVA.
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###### 

Click here for additional data file.

###### 

**Detection of endogenous β arrestin 1 and β arrestin 2 in cardiomyocytes by β arrestin 1 and β arrestin 2 antibodies.** Lane 1, cell lysate from HEK293 cells transiently expressing β arrestin 1-GFP; Lane 2, cell lysate from HEK293 cells transiently expressing β arrestin 2-GFP; Lane 3, cell lysate from neonatal cardiomyocytes.
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###### 

Click here for additional data file.

###### 

**β~1~β~2~AR-KO cardiomyocytes expressing β~2~ARs were lysed for detection of PKA phosphorylation of serine 261/262 by anti-phospho-serine 261/262 specific antibody.** Western blots were quantified and normalized against the total β~2~AR expression. \*, p\<0.05 in comparison to WT control stimulated with Iso alone by *t*-test.

(EPS)

###### 

Click here for additional data file.

###### 

β~1~β~2~AR-KO cardiomyocytes transiently expressing β~2~AR (A) or β~2~AR-C341A (B) along with cAMP FRET biosensor ICUE3 were pretreated with PTX (300 ng/ml) for 2 hours before stimulation with 10 µM isoproterenol. The changes in cAMP FRET over baseline level were recorded. The maximal changes over the basal levels were plotted. \*, p\<0.05 in comparison to WT control stimulated with Iso alone by one-way ANOVA.

(EPS)

###### 

Click here for additional data file.
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